Effect of Vojta or Reflex locomotion therapy on the gross motor function of children with cerebral palsy
Organizational Data
- DRKS-ID:
- DRKS00014775
- Recruitment Status:
- Recruiting stopped (after recruiting started)
- Date of registration in DRKS:
- 2018-05-25
- Last update in DRKS:
- 2020-05-08
- Registration type:
- Retrospective
Acronym/abbreviation of the study
VTCP
URL of the study
No Entry
Brief summary in lay language
The goal of this study is to quantify improvements on the speed of motor development in children with cerebral palsy, when a Vojta or Reflexlocomotion therapy program is implemented. Vojta Therapy is a physiotherapy technique widely used in the paediatric rehabilition. The hipothesis is that this therapy can increase the speed of gross motor function at early stages of this condition. Therefore, children at risk of neurological conditions under 18 month of age could participate in this study.
Brief summary in scientific language
Gross motor function and mobility have important roles for classification, assessment and research involving children with neuromotor disorders. Gross Motor Function Measure (GMFM) could be currently considered as gold standard for the quantification of gross motor function in the pediatric rehabilitation. These follow ups of thousands of children with cerebral palsy described the long term development of their gross motor function and defined five unalterable levels of severity. By the age of six, stability over time on the prognosticated level of mobility is expected. Even if GMFM was not designed to assess outcomes of therapeutic interventions, some author used its centiles to compare individual long term effects. On the other hand, uncompleted items of GMFM assessments are used as short term therapeutic goals and therefore, individually controlled comparison of the speed of acquisition of gross motor function seems to be possible within each range. Reflex Locomotion (RL) or Vojta Therapy has been reported clinically beneficial for strength, movement and motor activities in individual cases and is being considered within the second of three levels of evidence in interventions for cerebral palsy . Poor study design casted a shadow over the positive results in previous studies about Reflex Locomotion including lack of random sequence generation, concealed allocation, study blinding, incomplete outcome data collection and selective reporting. RL therapy was developed by Prof Vojta and uses locomotor patterns activated “reflexogenically”. Reflex Locomotion does not refer to the neuronal regulation, but is rather related to therapeutically applied external stimuli and their automatic movement responses. The afferent input of RL therapy generates important cortical and subcortical changes, especially in the ipsilateral putamen. The resulting outputs are differential responses that seem to be located in the brainstem and cerebellum, pontomedullary reticular formation and posterior cerebellar hemisphere and vermis. These automatic motor patterns aim to change task-related motor activation and its associated postural control , as well as to release and facilitate the development of the ontogenic postural function. RL Therapy has been reported clinically beneficial for strength, movement and motor activities in individual cases and is being considered within the second of three levels of evidence in interventions for cerebral palsy . Poor study design casted a shadow over the positive results in previous studies about RL including lack of random sequence generation, concealed allocation, study blinding, incomplete outcome data collection and selective reporting. The ethical limitations of randomized untreated control groups or placebo interventions limit the quality of the intervention in this field. Family participation in the decision making process is highly emphasized, and its integration on the therapeutic handling reduces economic cost and commuting times, and increases the dosing possibilities. The automatic motor patterns activated with Reflex Locomotion therapy aim to change task-related motor activation and its associated postural control , as well as to release and facilitate the development of the ontogenic postural function. Because functional training of compensatory strategies is not emphasized, gross motor improvements after Reflex Locomotion intervention seems to depend on the activation of the postural frame required for their acquisition, reducing compensatory strategies during the subsequent environment exposure. Our hypothesis is that there is an improvement on the postural function and therefore, on the speed of acquisition of gross motor function from the first weeks of application of Reflex Locomotion Therapy in children with neuromotor disorders. The purposes of this trial were to understand the effect of Reflex Locomotion therapy on the GMFM of children with cerebral palsy without specific training of its items, as well as to understand what role plays its dosage. METHODS Our clinical trial was designed to quantify changes in gross motor function after two months of Reflex Locomotion intervention. Children carried on clinically with the intervention but this short period would allow us to attribute changes to Reflex Locomotion, controlling better the influence of other factor (such as age maturation or other therapy inputs). This design will not allow us to understand long term effects, but the potentiality to facilitate motor and postural function development.
Health condition or problem studied
- ICD10:
- G80 - Cerebral palsy
- Healthy volunteers:
- No Entry
Interventions, Observational Groups
- Arm 1:
- RL therapy will be carried out once a week for 2 months, by a trained physiotherapist. This therapist will also train the parents in the exercises to establish a daily home program (between one and four times per day). Therapist administer pressure to defined zones on the body in a patient who is in a prone, supine or side lying position. Two movement complexes will be used: “reflex creeping” and “reflex rolling”.
Endpoints
- Primary outcome:
- Outcome Name: Gross motor function Method of measuremente: Gross Motor Funcion Measure (GMFM). Timepoint: after 2 months of treatment
- Secondary outcome:
- Outcome Name: Therapy Dossagement Method of measuremente: Times/day Timepoint: after 2 months of treatment
Study Design
- Purpose:
- Treatment
- Allocation:
- N/A (single arm study)
- Control:
-
- Uncontrolled/single arm
- Phase:
- N/A
- Study type:
- Interventional
- Mechanism of allocation concealment:
- No Entry
- Blinding:
- No
- Assignment:
- Single (group)
- Sequence generation:
- No Entry
- Who is blinded:
- No Entry
Recruitment
- Recruitment Status:
- Recruiting stopped (after recruiting started)
- Reason if recruiting stopped or withdrawn:
- Due to Covid19 crisis, the assessment and treatment of pacients cannot be currently carried out. Due to the uncertain situation, recruitment in Germany could not be started and therefore temporary closing of the trial has been agreed to. Calculations will be done with the current sample already recruited.
Recruitment Locations
- Recruitment countries:
-
- Germany
- Spain
- United Kingdom
- Number of study centers:
- Multicenter study
- Recruitment location(s):
-
- Doctor's practice Siegen
- Other Balance physiotherapy performance LTD. London (United Kingdom)
- University medical center Hospital Teresa Herrera. A Coruña University A Coruña (Spain)
- Other Clinica de Rehabilitacion. Madrid (Spain)
Recruitment period and number of participants
- Planned study start date:
- 2018-05-04
- Actual study start date:
- 2018-05-04
- Planned study completion date:
- No Entry
- Actual Study Completion Date:
- No Entry
- Target Sample Size:
- 30
- Final Sample Size:
- 21
Inclusion Criteria
- Sex:
- All
- Minimum Age:
- 1 Months
- Maximum Age:
- 18 Months
- Additional Inclusion Criteria:
- Male and female between zero and 18 months of age with neurological findings consistent with neuromotor disorders were recruited when the family inquired Reflex Locomotion therapy in different physiotherapy clinics in Spain, Germany and London (United Kingdom). The diagnosis of cerebral palsy can not be always confirmed within such an early stage, and neuromuscular disorders or other conditions that could affect motor performance need to be ruled out; therefore, the data of the children were included retrospectively on a later stage when the diagnosis was confirmed. In addition, participants’ parents or guardians gave informed consent. The previous therapeutic trajectory was not considered within the exclusion criteria for two reasons: their effect would be already included within the speed of motor development before RL, and also because all the children were controlled with themselves.
Exclusion Criteria
Data of the children are excluded if they introduced another therapy input or they dropped any of the previous ones during the two months of RL intervention (pharmacological, surgical or rehabilitative). For ethical reasons, this was not specified to the families who agreed to join the trial, in order not to influence their future therapeutic decisions.
Addresses
Primary Sponsor
- Address:
- Faculty of Medicine, University of Murcia, Spain. V. de la Arrixaca University Hospital, Department of Traumatology, Murcia, Spain.Dr. PhD in Medicine Fernando Santonja-MedinaCalle Francisco Jimenez Ruiz, 2730110 MurciaSpain
- Telephone:
- +34666594989
- Fax:
- +34666594989
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.santonjatrauma.es
- Investigator Sponsored/Initiated Trial (IST/IIT):
- Yes
Contact for Scientific Queries
- Address:
- University of MurciaDr. PhD in Physiotherapy Jose Manuel Sanz-Mengibar7 Newberry MewsSW4 7EL LondonUnited Kingdom
- Telephone:
- +447726764081
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.vojta.co.uk
Contact for Public Queries
- Address:
- University of MurciaPhD in Physiotherapy Jose Manuel Sanz-Mengibar7 Newberry MewsSW4 7EL LondonUnited Kingdom
- Telephone:
- +447726764081
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.vojta.co.uk
Principal Investigator
- Address:
- University of MurciaDr. PhD in Physiotherapy Jose Manuel Sanz-Mengibar7 Newberry MewsSW4 7EL LondonUnited Kingdom
- Telephone:
- +447726764081
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.vojta.co.uk
Sources of Monetary or Material Support
Institutional budget, no external funding (budget of sponsor/PI)
- Address:
- University of Murcia7 Newberry MewsSW4 7EL LondonUnited Kingdom
- Telephone:
- +447726764081
- Fax:
- No Entry
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.vojta.co.uk
Ethics Committee
Address Ethics Committee
- Address:
- Comisión de Ética de Investigación de la Universidad de Murcia [Murcia University (Spain)]Dr. Phd Antonio Juan García FernándezVicerrectorado de Investigación. UNIVERSIDAD DE MURCIA. Campus de Espinardo30071 MurciaSpain
- Telephone:
- 0034868883614
- Fax:
- 0034868883614
- Contact per E-Mail:
- Contact per E-Mail
- URL:
- http://www.um.es/web/comision-etica-investigacion/
Vote of leading Ethics Committee
- Vote of leading Ethics Committee
- Date of ethics committee application:
- 2018-03-01
- Ethics committee number:
- ID: 1823/2018
- Vote of the Ethics Committee:
- Approved
- Date of the vote:
- 2018-03-09
Further identification numbers
- Other primary registry ID:
- No Entry
- EudraCT Number:
- No Entry
IPD - Individual Participant Data
- Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
- No Entry
- IPD Sharing Plan:
- No Entry
Study protocol and other study documents
- Study protocols:
- No Entry
- Study abstract:
- No Entry
- Other study documents:
- No Entry
- Background literature:
- No Entry
- Related DRKS studies:
- No Entry
Publication of study results
- Planned publication:
- No Entry
- Publikationen/Studienergebnisse:
- No Entry
- Date of first publication of study results:
- No Entry
- DRKS entry published for the first time with results:
- No Entry
Basic reporting
- Basic Reporting / Results tables:
- No Entry
- Brief summary of results:
- No Entry